Matches in Wikidata for { <http://www.wikidata.org/entity/Q91042501> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q91042501 description "article scientifique publié en 2019" @default.
- Q91042501 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91042501 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91042501 description "scientific article published on 28 October 2019" @default.
- Q91042501 description "wetenschappelijk artikel" @default.
- Q91042501 description "наукова стаття, опублікована 28 жовтня 2019" @default.
- Q91042501 name "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 name "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 type Item @default.
- Q91042501 label "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 label "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 prefLabel "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 prefLabel "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 P1433 Q91042501-38EE5867-3BEC-4745-A3B8-ACB1CA1AEF5E @default.
- Q91042501 P1476 Q91042501-BFC791BA-580D-4698-8A42-EBD96149CE62 @default.
- Q91042501 P2093 Q91042501-08B518D6-2200-4325-ADDF-FCFEB9F63EF0 @default.
- Q91042501 P2093 Q91042501-0E85C274-A39B-4F2F-B3BF-6763E2F30667 @default.
- Q91042501 P2093 Q91042501-2BB19BBF-06D3-458B-9271-D395BEEBE473 @default.
- Q91042501 P2093 Q91042501-46667E38-A3DA-4F2C-AADF-80941206CDF5 @default.
- Q91042501 P2093 Q91042501-4D3F614A-307D-4ECD-B161-FE02B6D83409 @default.
- Q91042501 P2093 Q91042501-56488613-64FA-4CE9-A799-9DA072BD2D3E @default.
- Q91042501 P2093 Q91042501-5A7F4E3D-FBC6-47A9-9C4D-9252E380A506 @default.
- Q91042501 P2093 Q91042501-92BA9144-CFD2-4495-B8D4-74F5F955E3CC @default.
- Q91042501 P2093 Q91042501-9558AFA4-A5CB-4C3F-9188-96CFD9D7CC5F @default.
- Q91042501 P2093 Q91042501-A6EAB9BA-183A-4005-9BB1-487A3DDD19C6 @default.
- Q91042501 P2093 Q91042501-B314FB07-E897-4EC9-B93A-E443FB311DED @default.
- Q91042501 P2093 Q91042501-D55C9442-C94C-475D-979B-EF0822D5275B @default.
- Q91042501 P2093 Q91042501-D9A5C029-3422-4708-89DC-5FAA2BEC5F39 @default.
- Q91042501 P2093 Q91042501-DD055A55-4542-4CE9-9FE9-C57AD053FEF2 @default.
- Q91042501 P2093 Q91042501-E9832623-A92D-4377-B791-426501008933 @default.
- Q91042501 P304 Q91042501-17C23F29-FA45-450B-90DC-D3EEF0452F8C @default.
- Q91042501 P31 Q91042501-C0890FD0-F0FC-4EFA-A949-3866227D632B @default.
- Q91042501 P356 Q91042501-D58DD5B5-B130-40C0-AB66-A26C21DF2317 @default.
- Q91042501 P478 Q91042501-ABE27039-04A8-4222-8699-E654DAB034CD @default.
- Q91042501 P577 Q91042501-606290A9-1AE2-49FD-894F-BAACD32F3631 @default.
- Q91042501 P698 Q91042501-77C49153-4C0E-4D16-AF1F-E10144CC45E2 @default.
- Q91042501 P921 Q91042501-6A630742-C2C7-4F55-B682-790A154F7F53 @default.
- Q91042501 P921 Q91042501-C0488854-9EF3-4450-A660-A24161D3C08A @default.
- Q91042501 P356 J.DIABRES.2019.107904 @default.
- Q91042501 P698 31672500 @default.
- Q91042501 P1433 Q15750054 @default.
- Q91042501 P1476 "Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes" @default.
- Q91042501 P2093 "Hideki Kushima" @default.
- Q91042501 P2093 "Hiroe Nagaike" @default.
- Q91042501 P2093 "Makoto Ohara" @default.
- Q91042501 P2093 "Michishige Terasaki" @default.
- Q91042501 P2093 "Munenori Hiromura" @default.
- Q91042501 P2093 "Nobuko Sato" @default.
- Q91042501 P2093 "Satoshi Goto" @default.
- Q91042501 P2093 "Sho-Ichi Yamagishi" @default.
- Q91042501 P2093 "Takeshi Yamamoto" @default.
- Q91042501 P2093 "Tomoki Fujikawa" @default.
- Q91042501 P2093 "Tomoyasu Fukui" @default.
- Q91042501 P2093 "Toshiyuki Hayashi" @default.
- Q91042501 P2093 "Tsutomu Hirano" @default.
- Q91042501 P2093 "Yo Kohata" @default.
- Q91042501 P2093 "Yusaku Mori" @default.
- Q91042501 P304 "107904" @default.
- Q91042501 P31 Q13442814 @default.
- Q91042501 P356 "10.1016/J.DIABRES.2019.107904" @default.
- Q91042501 P478 "158" @default.
- Q91042501 P577 "2019-10-28T00:00:00Z" @default.
- Q91042501 P698 "31672500" @default.
- Q91042501 P921 Q3025883 @default.
- Q91042501 P921 Q95987978 @default.